StockData
Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) stock

DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$16.70−0.46 (-2.68%)

Close on Nov 16, 2026Market cap $3.12BP/E –Yield –

Dyne Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Dyne Therapeutics's market cap was $2.98B on Nov 11, 2026, against $3.12B a year earlier. Over the last 5 years it ranged from $248.43M to $4.61B, with a median of $1.36B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.98B+6.8%
2025Dec 31, 2025$2.79B+16.4%
2024Dec 31, 2024$2.40B+193.9%
2023Dec 29, 2023$815.59M+35.6%
2022Dec 30, 2022$601.60M-1.7%
2021Dec 31, 2021$612.14M-35.2%
2020Dec 31, 2020$945.09M–

More Dyne Therapeutics figures

See a number that looks wrong?